EPRS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.135200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.342400E-01
Normal-vs-Stage2
5.064600E-01
Normal-vs-Stage3
6.009200E-01
Normal-vs-Stage4
8.809700E-02
Stage1-vs-Stage2
4.581400E-01
Stage1-vs-Stage3
1.794000E-01
Stage1-vs-Stage4
4.666200E-01
Stage2-vs-Stage3
2.530600E-01
Stage2-vs-Stage4
1.035840E-01
Stage3-vs-Stage4
4.048100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.422200E-01
Normal-vs-AfricanAmerican
6.194200E-02
Normal-vs-Asian
8.105600E-01
Caucasian-vs-AfricanAmerican
3.599500E-02
Caucasian-vs-Asian
5.302000E-01
AfricanAmerican-vs-Asian
5.519800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.853200E-01
Normal-vs-Female
5.505600E-01
Male-vs-Female
6.756400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.706400E-01
Normal-vs-Age(41-60Yrs)
3.838200E-01
Normal-vs-Age(61-80Yrs)
5.848400E-01
Normal-vs-Age(81-100Yrs)
4.324400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.550000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.266400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.169600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.649200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.469800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.890400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.796000E-01
Normal-vs-Daily Drinker
9.500200E-01
Normal-vs-Weekly Drinker
6.743600E-01
Normal-vs-Occasional Drinker
2.618000E-01
Normal-vs-Social Drinker
4.050800E-01
Non Drinker-vs-Daily Drinker
3.347800E-01
Non Drinker-vs-Weekly Drinker
8.141400E-01
Non Drinker-vs-Occasional Drinker
6.631700E-02
Non Drinker-vs-Social Drinker
2.621400E-01
Daily Drinker-vs-Weekly Drinker
3.608000E-01
Daily Drinker-vs-Occasional Drinker
1.914030E-02
Daily Drinker-vs-Social Drinker
8.808400E-02
Weekly Drinker-vs-Occasional Drinker
2.444000E-01
Weekly Drinker-vs-Social Drinker
5.184000E-01
Occasional Drinker-vs-Social Drinker
6.036800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.600200E-01
Normal-vs-Grade 2
1.208010E-01
Normal-vs-Grade 3
7.227500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.381000E-01
Grade 1-vs-Grade 3
1.564020E-01
Grade 1-vs-Grade 4
2.600200E-01
Grade 2-vs-Grade 3
4.748400E-01
Grade 2-vs-Grade 4
1.208010E-01
Grade 3-vs-Grade 4
7.227500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.955200E-01
Normal-vs-NonDiabetic
5.917600E-01
Diabetic-vs-NonDiabetic
6.844000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.858200E-01
Normal-vs-NoPancreatitis
5.753600E-01
Pancreatitis-vs-NoPancreatitis
5.694400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.773000E-01
Normal-vs-N1
5.551200E-01
N0-vs-N1
2.483200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.216800E-01
Normal-vs-TP53-NonMutant
3.573000E-01
TP53-Mutant-vs-TP53-NonMutant
3.231000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
